These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 11092981)

  • 1. Apoptotic cytotoxic effects of a histone deacetylase inhibitor, FK228, on malignant lymphoid cells.
    Murata M; Towatari M; Kosugi H; Tanimoto M; Ueda R; Saito H; Naoe T
    Jpn J Cancer Res; 2000 Nov; 91(11):1154-60. PubMed ID: 11092981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of FK228, a novel histone deacetylase inhibitor, on human lymphoma U-937 cells in vitro and in vivo.
    Sasakawa Y; Naoe Y; Inoue T; Sasakawa T; Matsuo M; Manda T; Mutoh S
    Biochem Pharmacol; 2002 Oct; 64(7):1079-90. PubMed ID: 12234611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytotoxic effects of histone deacetylase inhibitor FK228 (depsipeptide, formally named FR901228) in combination with conventional anti-leukemia/lymphoma agents against human leukemia/lymphoma cell lines.
    Kano Y; Akutsu M; Tsunoda S; Izumi T; Kobayashi H; Mano H; Furukawa Y
    Invest New Drugs; 2007 Feb; 25(1):31-40. PubMed ID: 16865529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apoptosis induced by the histone deacetylase inhibitor FR901228 in human T-cell leukemia virus type 1-infected T-cell lines and primary adult T-cell leukemia cells.
    Mori N; Matsuda T; Tadano M; Kinjo T; Yamada Y; Tsukasaki K; Ikeda S; Yamasaki Y; Tanaka Y; Ohta T; Iwamasa T; Tomonaga M; Yamamoto N
    J Virol; 2004 May; 78(9):4582-90. PubMed ID: 15078940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histone deacetylase inhibitor FK228 inhibits tumor angiogenesis.
    Kwon HJ; Kim MS; Kim MJ; Nakajima H; Kim KW
    Int J Cancer; 2002 Jan; 97(3):290-6. PubMed ID: 11774279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histone deacetylase inhibitor depsipeptide (FK228) induces apoptosis in leukemic cells by facilitating mitochondrial translocation of Bax, which is enhanced by the proteasome inhibitor bortezomib.
    Sutheesophon K; Kobayashi Y; Takatoku MA; Ozawa K; Kano Y; Ishii H; Furukawa Y
    Acta Haematol; 2006; 115(1-2):78-90. PubMed ID: 16424655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The histone deacetylase inhibitor AN-9 has selective toxicity to acute leukemia and drug-resistant primary leukemia and cancer cell lines.
    Batova A; Shao LE; Diccianni MB; Yu AL; Tanaka T; Rephaeli A; Nudelman A; Yu J
    Blood; 2002 Nov; 100(9):3319-24. PubMed ID: 12384433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The histone deacetylase inhibitor FK228 distinctly sensitizes the human leukemia cells to retinoic acid-induced differentiation.
    Savickiene J; Treigyte G; Borutinskaite V; Navakauskiene R; Magnusson KE
    Ann N Y Acad Sci; 2006 Dec; 1091():368-84. PubMed ID: 17341629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of the histone deacetylase inhibitor depsipeptide on B-cell differentiation in both TEL-AML1-positive and negative childhood acute lymphoblastic leukemia.
    Stams WA; den Boer ML; Beverloo HB; Kazemier KM; van Wering ER; Janka-Schaub GE; Pieters R
    Haematologica; 2005 Dec; 90(12):1697-9. PubMed ID: 16330447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FR901228, a novel histone deacetylase inhibitor, induces cell cycle arrest and subsequent apoptosis in refractory human pancreatic cancer cells.
    Sato N; Ohta T; Kitagawa H; Kayahara M; Ninomiya I; Fushida S; Fujimura T; Nishimura G; Shimizu K; Miwa K
    Int J Oncol; 2004 Mar; 24(3):679-85. PubMed ID: 14767553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo effects of a histone deacetylase inhibitor, FK228, on human acute promyelocytic leukemia in NOD / Shi-scid/scid mice.
    Kosugi H; Ito M; Yamamoto Y; Towatari M; Ito M; Ueda R; Saito H; Naoe T
    Jpn J Cancer Res; 2001 May; 92(5):529-36. PubMed ID: 11376562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of p53, ErbB1, ErbB2, and Raf-1 expression in lung cancer cells by depsipeptide FR901228.
    Yu X; Guo ZS; Marcu MG; Neckers L; Nguyen DM; Chen GA; Schrump DS
    J Natl Cancer Inst; 2002 Apr; 94(7):504-13. PubMed ID: 11929951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histone deacetylase inhibitor, FK228, induces apoptosis and suppresses cell proliferation of human glioblastoma cells in vitro and in vivo.
    Sawa H; Murakami H; Kumagai M; Nakasato M; Yamauchi S; Matsuyama N; Tamura Y; Satone A; Ide W; Hashimoto I; Kamada H
    Acta Neuropathol; 2004 Jun; 107(6):523-31. PubMed ID: 15024582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FK228 (depsipeptide): a HDAC inhibitor with pleiotropic antitumor activities.
    Konstantinopoulos PA; Vandoros GP; Papavassiliou AG
    Cancer Chemother Pharmacol; 2006 Nov; 58(5):711-5. PubMed ID: 16435156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of the tumor necrosis factor (TNF)/TNF receptor system in leukemic cell apoptosis induced by histone deacetylase inhibitor depsipeptide (FK228).
    Sutheesophon K; Nishimura N; Kobayashi Y; Furukawa Y; Kawano M; Itoh K; Kano Y; Ishii H; Furukawa Y
    J Cell Physiol; 2005 May; 203(2):387-97. PubMed ID: 15515013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical, biological and structural properties of romidepsin (FK228) and its analogs as novel HDAC/PI3K dual inhibitors.
    Saijo K; Imamura J; Narita K; Oda A; Shimodaira H; Katoh T; Ishioka C
    Cancer Sci; 2015 Feb; 106(2):208-15. PubMed ID: 25492515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FR901228, a potent antitumor antibiotic, is a novel histone deacetylase inhibitor.
    Nakajima H; Kim YB; Terano H; Yoshida M; Horinouchi S
    Exp Cell Res; 1998 May; 241(1):126-33. PubMed ID: 9633520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of p21waf1/cip1 expression in the cytotoxicity of the potent histone deacetylase inhibitor spiruchostatin B towards susceptible NALM-6 human B cell leukemia cells.
    Kanno S; Maeda N; Tomizawa A; Yomogida S; Katoh T; Ishikawa M
    Int J Oncol; 2012 May; 40(5):1391-6. PubMed ID: 22211246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histone deacetylase inhibitor FK228 suppresses the Ras-MAP kinase signaling pathway by upregulating Rap1 and induces apoptosis in malignant melanoma.
    Kobayashi Y; Ohtsuki M; Murakami T; Kobayashi T; Sutheesophon K; Kitayama H; Kano Y; Kusano E; Nakagawa H; Furukawa Y
    Oncogene; 2006 Jan; 25(4):512-24. PubMed ID: 16186804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiproliferative effects of the histone deacetylase inhibitor FR901228 on small-cell lung cancer lines and drug-resistant sublines.
    Tsurutani J; Soda H; Oka M; Suenaga M; Doi S; Nakamura Y; Nakatomi K; Shiozawa K; Amada YY; Kamihira S; Kohno S
    Int J Cancer; 2003 Mar; 104(2):238-42. PubMed ID: 12569581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.